What are the recommended antibiotics and dosages for the treatment of chorioamnionitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Antibiotics and Dosages for Chorioamnionitis Treatment

The standard first-line antimicrobial regimen for chorioamnionitis consists of intravenous ampicillin (2g initial dose, then 1g every 4 hours) plus gentamicin (5 mg/kg based on ideal body weight as a single daily dose), with clindamycin (900mg every 8 hours) added at cord clamping for cesarean deliveries. 1

First-Line Treatment Regimen

For All Patients with Chorioamnionitis:

  • Ampicillin: 2g IV initial dose, then 1g IV every 4 hours until delivery 2, 1
  • Gentamicin: 5 mg/kg IV (based on ideal body weight) as a single daily dose 1, 3, 4
    • Daily dosing of gentamicin shows lower risk of postpartum endometritis (64% reduction) compared to traditional 8-hour dosing 3

For Patients Undergoing Cesarean Delivery:

  • Add Clindamycin: 900mg IV at umbilical cord clamping 5, 6
    • Provides additional anaerobic coverage needed for cesarean deliveries

Penicillin-Allergic Patients

For patients with penicillin allergy:

  • Low risk for anaphylaxis: Cefazolin 2g IV initial dose, then 1g IV every 8 hours 2
  • High risk for anaphylaxis (history of anaphylaxis, angioedema, respiratory distress, or urticaria):
    • Vancomycin: 1g IV every 12 hours 2
    • Clindamycin: 900mg IV every 8 hours (only if GBS isolate is confirmed susceptible) 2

Duration of Treatment

  • For vaginal delivery: Limited course therapy is highly effective - administer only the next scheduled dose of each antibiotic after delivery 6, 7
    • 99% success rate for vaginal deliveries with this approach 7
  • For cesarean delivery: Continue antibiotics for one additional dose after delivery 6
    • Some patients who deliver by cesarean may benefit from extended therapy, particularly those with risk factors such as obesity, prolonged labor, or prolonged rupture of membranes 7

Alternative Regimens for Special Circumstances

  • For suspected resistant organisms or polymicrobial infections: Consider broader spectrum agents such as piperacillin/tazobactam (Zosyn) 1
  • For refractory cases: Consider a regimen including ceftriaxone, clarithromycin, and metronidazole 5

Newborn Management

  • Well-appearing newborns whose mothers had chorioamnionitis should undergo a limited evaluation (blood culture, CBC with differential and platelet count) 2, 1
  • Empiric antibiotic therapy should be initiated pending culture results 2
  • Therapy for the infant should include antimicrobial agents active against GBS (including IV ampicillin) and coverage for other organisms like E. coli 2

Clinical Pearls and Pitfalls

  • Clindamycin should never be used if susceptibility testing of the mother's GBS isolate has not been performed, as approximately 20% of GBS isolates are resistant 2
  • The time interval between diagnosis of chorioamnionitis and delivery is not related to most adverse maternal and neonatal outcomes 5
  • Patients with chorioamnionitis may require higher doses of oxytocin to achieve adequate uterine activity 5
  • Vaginal cleansing with antiseptic solutions before cesarean delivery may decrease the risk of endometritis 5

Daily gentamicin dosing using ideal body weight represents a significant improvement over traditional 8-hour dosing, with research showing a 5% greater chance of successful outcome and significantly lower risk of endometritis 3, 4.

References

Guideline

Chorioamnionitis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Daily gentamicin using ideal body weight demonstrates lower risk of postpartum endometritis and increased chance of successful outcome compared with traditional 8-hour dosing for the treatment of intrapartum chorioamnionitis.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2019

Research

Management of clinical chorioamnionitis: an evidence-based approach.

American journal of obstetrics and gynecology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.